Most people who set out to start a peptide company think the hard part is the website. It is not. The hard part is that this category breaks the default assumptions of nearly every tool you would normally reach for, starting with your payment processor and ending with your ad account. This guide is what we have learned building and operating these systems for brands that are live and taking orders.
A peptide business needs nine systems, not one: a compliance posture, a storefront built around it, an age and identity gate, a payment rail that will actually approve you, a per-batch document library, an automated fulfillment path, an operations CRM, a channel structure for clinics and reps, and an organic visibility strategy, because you cannot reliably buy traffic in this category. The build is typically four to eight weeks. Payment underwriting, not development, is what usually sets your launch date.
Every downstream decision, including which processors will even talk to you, follows from one question: what are you actually selling, and to whom. In practice new entrants land in one of a few lanes. Research-use-only products sold to researchers and labs. Physician-directed products sold to licensed clinicians who administer or dispense them. Wholesale supply to other businesses that carry their own compliance obligations. These are genuinely different businesses with different language, different buyers and different risk.
The mistake is treating this as a legal detail to sort out after launch. Your posture determines the copy on every product page, whether you can show dosing information at all, what your age gate says, which processor category you fall into, and what a lab needs to certify. Retrofitting it later means rewriting the entire site, and usually re-underwriting your payments.
The practical rule we build to: if you are selling research-use-only, then nothing anywhere on the property, including blog posts, meta descriptions, email templates and anything an AI copy generator produced, may read as instructions for human use or as a medical claim. That is a constraint on the whole system, not on one page. It is also the single most common reason a processor application is rejected after a compliance review of the site.
Three starting points, and the build differs less than people expect. If you already have a supplier, the work is integration: pull their catalog in, map SKUs, sync stock so an item that sells out at their end stops selling at yours, wire their warehouse so paid orders release automatically, and present their lab documents under your branding. If you manufacture or compound yourself, the system has to be batch-aware instead, with lot numbers, per-lot certificates and stock you control, plus the wholesale and provider tiers to sell into clinics and other brands. If you have no supplier yet, that is a sourcing problem, not a technology problem: what you need is introductions to suppliers, labs and fulfillment warehouses, and help reading the pricing sheets, minimums, testing and lead times that come back.
The reason to settle this early is that it determines your catalog structure, your margin model and your fulfillment path, all three of which are expensive to change once you have live orders.
The storefront has two audiences that most builders forget: the customer, and the risk analyst at a payment processor who will read your site line by line before approving you. Both need the same things, which is convenient.
Two different gates get confused with each other. An age gate is a low-friction confirmation that the visitor is of age and understands the research-use terms. An identity gate is a real verification step, normally a one-time code sent by SMS, that proves a working phone number belongs to whoever is on the other end.
The age gate is table stakes. The identity gate is what changes the economics of your lead flow, because it means the contact records you collect are real, and it is a meaningful deterrent to the automated abuse this category attracts. On live builds we run this sitewide with a returning-visitor path, so a number that has already verified is remembered and does not generate a second message charge. That detail matters more than it sounds: without it, verification cost scales with page views instead of with people.
Design the failure mode deliberately. If the verification provider has an outage, do you lose every lead, or do you let them through tagged as unverified? For lead capture, failing open and tagging the record is usually correct. For a policy rule, such as restricting who may submit at all, failing open is wrong, because an outage becomes an open door. Those two cases need different code paths, and conflating them is a common security bug.
This is the section people wish they had read first.
Stripe, Square, PayPal and Shopify Payments all treat research peptides as prohibited or high risk. You will either be declined at underwriting, or, worse, approved and then frozen after your first strong month while the processor holds your balance. The second outcome is more damaging because you have already built a customer base and taken orders you now cannot fulfil or refund cleanly.
| Rail | Where it fits | What to expect |
|---|---|---|
| ACH / eCheck | The workhorse for most volume | Lower fees than high-risk cards, but funds settle rather than authorize, so you need a defined rule for when an order releases to the warehouse. Bank verification settings matter enormously: overly strict verification can decline nearly every legitimate customer. |
| Bank transfer apps | High-ticket and wholesale | Very low cost, no chargebacks, but confirmation is manual unless you build a reconciliation path. Practical at low order counts, needs tooling as you grow. |
| High-risk card processing | Consumer conversion | The best conversion of the three because customers expect a card field. Higher rates, likely a rolling reserve, and a real underwriting process that reviews your site. Approval timelines of two to six weeks are normal. |
| Crypto | Rarely the answer | Frequently recommended in forums, rarely converts for a mainstream customer base, and several providers have declined this category outright. |
Assume you will change processors at least once. Build checkout so the payment rail sits behind a single interface with the active provider chosen by configuration, and keep an inactive rail behind a flag so it can be switched on the day underwriting approves. Brands that weld one processor into their checkout end up rebuilding checkout under time pressure, usually during the exact week their revenue is frozen.
A certificate of analysis is the third-party lab report for a specific batch: identity and purity, typically by HPLC or mass spectrometry. Endotoxin testing is a separate report. Country of origin documentation matters for wholesale buyers and for customs questions.
Most stores treat these as a compliance chore and dump PDFs into a downloads page. That is a wasted asset. Buyers in this category are unusually document-literate, and the brands that win on trust are the ones where a customer holding a vial can find that exact batch in seconds.
Almost no early peptide brand holds its own inventory. A supplier warehouse or third-party logistics provider picks, packs and ships. That means fulfillment is an integration problem, and if you do not solve it with software, a human becomes the integration, forwarding order emails and pasting tracking numbers.
The pattern that works: expose paid orders to the warehouse through a store feed their system already understands, make marking an order paid the single event that releases it, and have the warehouse write the tracking number back automatically, which then triggers the customer email. Done properly, an order runs from placed, to settled, to released, to shipped, to tracking delivered, with nobody touching a keyboard.
Two details that bite: live carrier rates need a fallback, because when the rate API is slow or down, a checkout that cannot price shipping is a checkout that cannot take money, and free shipping thresholds must be calculated after discounts, or a promotion quietly hands out free freight.
Once orders exist, the storefront stops being the important software. The operations desk is. Off-the-shelf CRMs assume a sales pipeline; a peptide operation needs an order lifecycle, a channel hierarchy and a document trail.
Retail is the visible channel and usually the worst one. Margin, order size and repeat rate are all better through clinics, providers and wholesale accounts. Two systems unlock that.
Reps need their own portal and their own code, downline overrides so a manager earns on the team, commission rates that default to house terms but can be overridden per person, an onboarding pack with e-signature, and a materials library that issues time-limited links rather than public URLs. Commission configuration should be owner-only, so a sales manager can run the desk without being able to change what anyone earns.
A provider portal lets a clinician register, get verified against the NPI registry, and order at practice pricing without ever touching consumer checkout. Build the signup in two stages: credentials and identity first, payment details and tax information after the account exists. A single monolithic form that asks a physician for their license, banking details and card in one screen has a predictable abandonment rate.
Add an approval queue, and force a password reset on any temporary credential you issue, prompting on first login without locking anyone out who wants to do it later.
Google Ads and Meta both restrict this category, and enforcement is inconsistent and retroactive. Building a business on an ad account that may be disabled without warning is a structural risk, not a marketing preference.
What works instead:
A storefront with catalog, compliance layer, gating, COA library and one working payment rail is typically four to eight weeks of build. The operations layer, meaning CRM, reps, provider portal and fulfillment, is usually staged after launch unless you already have the channel.
The sequencing decision that matters most: start payment underwriting in parallel with the build, not after it. Underwriting commonly takes two to six weeks and requires a site the processor can review. Teams that build first and apply second routinely add two months to their launch for no reason.
On cost, the honest answer is that development is often not the largest number. Inventory and supplier minimums, third-party lab testing, entity and insurance setup, and the higher processing rates and rolling reserve that come with high-risk payments usually add up to more. Be suspicious of anyone who quotes this category from a price list without asking what you are selling and to whom.
If you are early, decide your compliance posture and start payment conversations this week, before you commission a single page of design. Those two decisions constrain everything else and have the longest lead times.
If you are already selling and the systems are what hurt, the fix is usually the operations layer rather than the storefront: get orders releasing automatically, get your channel structure into software, and get margin visible.
This guide is drawn from live implementations and is written for operators. It is general information about building the technical and operational systems a peptide company runs on, not legal, medical or regulatory advice. Requirements vary by product, jurisdiction and business model, so confirm your specific obligations with qualified counsel before launching.